These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 26296712

  • 1. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.
    Held PK, Shapira SK, Hinton CF, Jones E, Hannon WH, Ojodu J.
    Mol Genet Metab; 2015 Nov; 116(3):133-8. PubMed ID: 26296712
    [Abstract] [Full Text] [Related]

  • 2. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S.
    Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
    [Abstract] [Full Text] [Related]

  • 3. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
    Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524
    [Abstract] [Full Text] [Related]

  • 4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 5. Newborn screening for congenital adrenal hyperplasia.
    Therrell BL.
    Endocrinol Metab Clin North Am; 2001 Mar 17; 30(1):15-30. PubMed ID: 11344933
    [Abstract] [Full Text] [Related]

  • 6. Congenital adrenal hyperplasia and the second newborn screen.
    Chan CL, McFann K, Taylor L, Wright D, Zeitler PS, Barker JM.
    J Pediatr; 2013 Jul 17; 163(1):109-13.e1. PubMed ID: 23414665
    [Abstract] [Full Text] [Related]

  • 7. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia.
    Sarafoglou K, Banks K, Gaviglio A, Hietala A, McCann M, Thomas W.
    Pediatrics; 2012 Nov 17; 130(5):e1261-8. PubMed ID: 23071209
    [Abstract] [Full Text] [Related]

  • 8. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.
    Brosnan CA, Brosnan P, Therrell BL, Slater CH, Swint JM, Annegers JF, Riley WJ.
    Public Health Rep; 1998 Nov 17; 113(2):170-8. PubMed ID: 9719819
    [Abstract] [Full Text] [Related]

  • 9. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
    Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A.
    JAMA Pediatr; 2014 Jun 17; 168(6):567-74. PubMed ID: 24733564
    [Abstract] [Full Text] [Related]

  • 10. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
    Güran T, Tezel B, Çakır M, Akıncı A, Orbak Z, Keskin M, Selver Eklioğlu B, Ozon A, Özbek MN, Karagüzel G, Hatipoğlu N, Gürbüz F, Çizmecioğlu FM, Kara C, Şimşek E, Baş F, Aydın M, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2020 Sep 02; 12(3):287-294. PubMed ID: 32157855
    [Abstract] [Full Text] [Related]

  • 11. Single newborn screen or routine second screening for primary congenital hypothyroidism.
    Shapira SK, Hinton CF, Held PK, Jones E, Harry Hannon W, Ojodu J.
    Mol Genet Metab; 2015 Nov 02; 116(3):125-32. PubMed ID: 26293295
    [Abstract] [Full Text] [Related]

  • 12. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
    Eshragh N, Doan LV, Connelly KJ, Denniston S, Willis S, LaFranchi SH.
    Horm Res Paediatr; 2020 Nov 02; 93(2):128-136. PubMed ID: 32659761
    [Abstract] [Full Text] [Related]

  • 13. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G.
    J Paediatr Child Health; 2008 Oct 02; 44(10):554-9. PubMed ID: 19012627
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
    van der Linde AAA, Schönbeck Y, van der Kamp HJ, van den Akker ELT, van Albada ME, Boelen A, Finken MJJ, Hannema SE, Hoorweg-Nijman G, Odink RJ, Schielen PCJI, Straetemans S, van Trotsenburg PS, Claahsen-van der Grinten HL, Verkerk PH.
    Arch Dis Child; 2019 Jul 02; 104(7):653-657. PubMed ID: 30712004
    [Abstract] [Full Text] [Related]

  • 15. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C, Prado MJ, da Silva CMD, de Castro SM, Beltrão LA, Vargas PR, Grandi T, Rossetti MLR, Spritzer PM.
    J Pediatr (Rio J); 2019 Jul 02; 95(3):282-290. PubMed ID: 29715434
    [Abstract] [Full Text] [Related]

  • 16. Effect of newborn screening for congenital adrenal hyperplasia.
    Brosnan PG, Brosnan CA, Kemp SF, Domek DB, Jelley DH, Blackett PR, Riley WJ.
    Arch Pediatr Adolesc Med; 1999 Dec 02; 153(12):1272-8. PubMed ID: 10591305
    [Abstract] [Full Text] [Related]

  • 17. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep 02; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 18. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
    Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T.
    J Clin Endocrinol Metab; 2002 Sep 02; 87(9):4106-10. PubMed ID: 12213856
    [Abstract] [Full Text] [Related]

  • 19. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A, Konishi K, Hasegawa S, Anazawa A, Onishi T, Ono M, Morio T, Kitagawa T, Kashimada K.
    BMC Pediatr; 2015 Dec 15; 15():209. PubMed ID: 26671474
    [Abstract] [Full Text] [Related]

  • 20. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
    Clin Genet; 2012 Jul 15; 82(1):64-70. PubMed ID: 21534945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.